Allergy Diagnostics Market In Depth Analysis By bioMérieux SA, Romer Labs Division Holding

BRUSSELS - Aug. 10, 2022 - PRLog -- Allergies are the 6th leading cause of chronic illness in the U.S. and each year more than 50 million Americans experience various types of allergies. Constantly rising cases of allergic diseases and other related medical conditions has fueled the global allergy diagnostics market.

The Global Allergy Diagnostics Market valued at ~$4.9 billion (2021) is set to witness a healthy growth rate of 11% in the next 5 years. Growing cases of allergic diseases (asthma, allergic rhinitis, atopic dermatitis, and food allergy), rising environmental pollution levels, high volume consumption of processed food and beverages, advent of mHealth in allergy diagnosis & care and growing awareness about allergic diseases are some of the key factors driving the Global Allergy Diagnostics Market.

Growing Prominence of mHealth in Allergy Diagnosis & Allergy Care
The well-known availability of technology-based interventions such as mobile health in the clinical setting has enabled patients to play an active role in their medical care. Mobile health (mHealth) utilizes mobile communication devices such as computers, tablets and smartphones to improve patient education & self-management of diseases, help in remote surveillance of patient's health, flow of data and information and disease management from first diagnosis to an optimized treatment.

To Browse a Full Report with TOC: https://meditechinsights.com/allergy-diagnostics-market/

Competitive Landscape Analysis: Allergy Diagnostics Market
Some of the key players operating in the allergy diagnostics market are Thermo Fisher Scientific Inc., Siemens Healthineers , Danaher, Omega Diagnostics Group PLC, bioMérieux SA, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, NEOGEN Corporation, Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, HOB Biotech Group Corp., Ltd., HYCOR Biomedical, R-Biopharm AG, AESKU.GROUP GmbH, ACON Laboratories, Inc., Lincoln Diagnostics, Inc., Astra Biotech GmbH, Erba Group (UK), among others.

About Medi-Tech Insights:
Medi-Tech Insights is a healthcare-focused business research & insights firm. We have successfully completed 100+ projects in Healthcare IT, MedTech, Medical Devices & Pharma Services in the areas of due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry leading CXO, VPs and key demand/supply side decision-makers.

Contact Us:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com